Acute, Multiple-Dose Dermal and Genetic Toxicity of Nu-3: A Novel Antimicrobial Agent

Table 4

CHO/HGPRT mutation assay.

	Mutation frequency (mutants/1 × 10^6 clonable cells)
Groups	Activated	Nonactivated
Saline control	3.30	3.30
Positive control	244.0	187.0
Nu-3 (500 𝜇g/ml)	5.40	4.50
Nu-3 (1000 𝜇g/ml)	4.50	5.70
Nu-3 (2000 𝜇g/ml)	6.90	8.30